Close Menu

NEW YORK (GenomeWeb) – Affymetrix announced on Thursday that it has acquired the assets of Eureka Genomics, including its high-throughput crop and animal genotyping technology, for $15 million in cash.

Eureka's low- and mid-plex genotyping assays use common next-generation sequencing platforms for signal readout, and enable the detection of hundreds to thousands of genetic markers for crop and animal agrigenomics testing, according to Affymetrix.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Wall Street Journal reports that Russia's announcement of a coronavirus vaccine approval was met with concern as safety testing has not yet been completed.

New Scientist writes there aren't much data available on the accuracy of the two rapid COVID-19 tests the UK plans to roll out.

In PNAS this week: downstream effect of oncoprotein fusion, epigenetic changes influence tRNAs in colon cancer, and more.

Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.